How API Manufacturing Companies Can Redefine Their Pricing Strategy | Quantzig’s Success Story Offers Detailed Insights

Editorial & Advertiser Disclosure Global Banking And Finance Review is an independent publisher which offers News, information, Analysis, Opinion, Press Releases, Reviews, Research reports covering various economies, industries, products, services and companies. The content available on is sourced by a mixture of different methods which is not limited to content produced and supplied by various staff writers, journalists, freelancers, individuals, organizations, companies, PR agencies Sponsored Posts etc. The information available on this website is purely for educational and informational purposes only. We cannot guarantee the accuracy or applicability of any of the information provided at with respect to your individual or personal circumstances. Please seek professional advice from a qualified professional before making any financial decisions. also links to various third party websites and we cannot guarantee the accuracy or applicability of the information provided by third party websites. Links from various articles on our site to third party websites are a mixture of non-sponsored links and sponsored links. Only a very small fraction of the links which point to external websites are affiliate links. Some of the links which you may click on our website may link to various products and services from our partners who may compensate us if you buy a service or product or fill a form or install an app. This will not incur additional cost to you. A very few articles on our website are sponsored posts or paid advertorials. These are marked as sponsored posts at the bottom of each post. For avoidance of any doubts and to make it easier for you to differentiate sponsored or non-sponsored articles or links, you may consider all articles on our site or all links to external websites as sponsored . Please note that some of the services or products which we talk about carry a high level of risk and may not be suitable for everyone. These may be complex services or products and we request the readers to consider this purely from an educational standpoint. The information provided on this website is general in nature. Global Banking & Finance Review expressly disclaims any liability without any limitation which may arise directly or indirectly from the use of such information.

Quantzig is one of the worlds foremost providers of advanced data analytics solutions with business units spread globally. Our advanced analytics solutions and domain expertise empower us to look for insights in complex, unstructured data sets from disparate sources. With the new digital economy creating significant disruptions and new opportunities, our global team of over 550+ analytics experts work with leading companies to help master digital transformation, drawing on our deep domain expertise and understanding of factors impacting business growth. Our insights have helped leading Fortune 500 companies achieve better success rates by adopting the right technology and digital solutions to drive innovation and competitiveness. Request a FREE one-on-one platform demo to learn how our solutions can be tailored to your specific business requirements.

Engagement Overview:

Pharmaceutical industry players can drastically improve their understanding of what drives their customers buying decisions by leveraging advanced analytics for demand forecasting, combined with a robust pricing strategy, a method used by most of the businesses to aptly price their products/services taking into account expenses such as manufacturing, packaging and shipping, marketing, and adding a profit margin to it. An API manufacturer collaborated with Quantzig to leverage its expertise in pharmaceutical pricing to redefine their pricing strategy in the USA.

Get your FREE customized proposal to know how we can help you to redefine your pricing strategy across the globe.

The Problem:

The client is an European API manufacturing company based out of Germany, well-known for manufacturing biologically active pharmaceutical drugs. This API manufacturer was looking forward to launching a new line of products in the USA. The client was facing difficulties in devising a pharmaceutical pricing strategy. The client wanted to accomplish the following goals “

  1. Devise a value-based penetration pharmaceutical pricing strategy for launching their product line in the US
  2. Derive a drug price benchmarking model for the US market
  3. Analyze the competitive landscape in the pharmaceutical industry

To devise a value-based pricing strategy for your business request for more info.

Value Delivered:

The experts at Quantzig conducted a holistic research to understand the clients competition and their pricing strategy (drug price benchmarking), while taking into account the hidden factors that could impact the products price. Quantzigs pricing analytics solutions curated for the pharmaceutical industry enabled this API manufacturer to “

  • Save US $12,00,000 by implementing advanced drug price benchmarking
  • Drive sales and obtain a higher return on investment
  • Improve drug pricing transparency
  • Redefine their pricing strategy across the globe

A pharmaceutical pricing strategy revolves around a solid understanding of the complete decision-making process. Armed with data-driven insights, our pharmaceutical clients execute value-driven drug price benchmarking to optimize profits, says a pricing analytics expert from Quantzig.

Over the past 15 years, Quantzig has helped Fortune 500 companies solve some of the toughest business problems using a unique combination of design thinking frameworks, plug-and-play innovation accelerators, and an army of agile decision scientists. Want to know more? Contact us for a free pilot.

About Quantzig

Quantzig is a global analytics and advisory firm with offices in the US, UK, Canada, China, and India. For more than 15 years, we have assisted our clients across the globe with end-to-end data modeling capabilities to leverage analytics for prudent decision making. Today, our firm consists of 120+ clients, including 55 Fortune 500 companies. For more information on our engagement policies and pricing plans, visit:

Press Contact


Anirban Choudhury

Marketing Manager

US: +1 630 538 7144

UK: +44 208 629 1455